Alphabet’s Verily Life Sciences racks up $700m: Reuters

Verily Life Sciences LLC, Alphabet Inc’s life sciences division, has raised $700 million in funding, reported Reuters.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this